| Aug 22 |
Cyclo Therapeutics falls after merger agreement with Rafael Holdings
|
| Aug 22 |
Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement
|
| Aug 17 |
Cyclo Therapeutics Second Quarter 2024 Earnings: Misses Expectations
|
| Jul 29 |
Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office
|
| Jun 25 |
Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024
|
| Jun 14 |
Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results
|
| May 30 |
Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1
|
